These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10091694)

  • 1. Symmetrical anhydride-type serine protease inhibitors: structure-activity relationship studies of human chymase inhibitors.
    Iijima K; Katada J; Hayashi Y
    Bioorg Med Chem Lett; 1999 Feb; 9(3):413-8. PubMed ID: 10091694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationship studies of chloromethyl ketone derivatives for selective human chymase inhibitors.
    Hayashi Y; Iijima K; Katada J; Kiso Y
    Bioorg Med Chem Lett; 2000 Feb; 10(3):199-201. PubMed ID: 10698435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a stable chymase inhibitor using a pharmacophore-Based database search.
    Koide Y; Tatsui A; Hasegawa T; Murakami A; Satoh S; Yamada H; Kazayama S; Takahashi A
    Bioorg Med Chem Lett; 2003 Jan; 13(1):25-9. PubMed ID: 12467610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonpeptidic chymase inhibitors: design and structure-activity relationships of pyrimidinone derivatives based on the predicted binding mode of a peptidic inhibitor.
    Akahoshi F
    Curr Pharm Des; 2003; 9(15):1191-9. PubMed ID: 12769746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1-Oxacephem-based human chymase inhibitors: discovery of stable inhibitors in human plasma.
    Aoyama Y; Uenaka M; Konoike T; Iso Y; Nishitani Y; Kanda A; Naya N; Nakajima M
    Bioorg Med Chem Lett; 2000 Nov; 10(21):2403-6. PubMed ID: 11078188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and structure-activity relationships of a new class of 1-oxacephem-based human chymase inhibitors.
    Aoyama Y; Uenaka M; Konoike T; Iso Y; Nishitani Y; Kanda A; Naya N; Nakajima M
    Bioorg Med Chem Lett; 2000 Nov; 10(21):2397-401. PubMed ID: 11078187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptidyl human heart chymase inhibitors. 2. Discovery of highly selective difluoromethylene ketone derivatives with Glu at P3 site.
    Eda M; Ashimori A; Akahoshi F; Yoshimura T; Inoue Y; Fukaya C; Nakajima M; Fukuyama H; Imada T; Takai S; Shiota N; Miyazaki M; Nakamura N
    Bioorg Med Chem Lett; 1998 Apr; 8(8):919-24. PubMed ID: 9871512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and pharmacological evaluation of 3-benzylazetidine-2-one-based human chymase inhibitors.
    Aoyama Y; Uenaka M; Kii M; Tanaka M; Konoike T; Hayasaki-Kajiwara Y; Naya N; Nakajima M
    Bioorg Med Chem; 2001 Nov; 9(11):3065-75. PubMed ID: 11597491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of indole and tetrahydroisoquinoline hydantoin derivatives as human chymase inhibitors.
    Alagille D; Pfeiffer B; Scalbert E; Ferry G; Boutin JA; Renard P; Viaud-Massuard MC
    J Enzyme Inhib Med Chem; 2004 Apr; 19(2):137-43. PubMed ID: 15449728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chymase-directed serine protease inhibitor that reacts with a single 30-kDa granzyme and blocks NK-mediated cytotoxicity.
    Woodard SL; Jackson DS; Abuelyaman AS; Powers JC; Winkler U; Hudig D
    J Immunol; 1994 Dec; 153(11):5016-25. PubMed ID: 7963562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substituted 3-phenylsulfonylquinazoline-2,4-dione derivatives as novel nonpeptide inhibitors of human heart chymase.
    Fukami H; Imajo S; Ito A; Kakutani S; Shibata H; Sumida M; Tanaka T; Niwata S; Saitoh M; Kiso Y; Miyazaki M; Okunishi H; Urata H; Arakawa K
    Drug Des Discov; 2000; 17(1):69-84. PubMed ID: 10928450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diverse effects of pH on the inhibition of human chymase by serpins.
    Schechter NM; Plotnick M; Selwood T; Walter M; Rubin H
    J Biol Chem; 1997 Sep; 272(39):24499-507. PubMed ID: 9305913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Syntheses and evaluation of amidinobenzofuran derivatives as tryptase inhibitors.
    Ono S; Kuwahara S; Takeuchi M; Sakashita H; Naito Y; Kondo T
    Bioorg Med Chem Lett; 1999 Dec; 9(23):3285-90. PubMed ID: 10612586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based design, synthesis, and binding mode analysis of novel and potent chymase inhibitors.
    Futamura-Takahashi J; Tanaka T; Sugawara H; Iwashita S; Imajo S; Oyama Y; Muto T
    Bioorg Med Chem Lett; 2018 Jan; 28(2):188-192. PubMed ID: 29191554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soybean Bowman-Birk protease inhibitor is a highly effective inhibitor of human mast cell chymase.
    Ware JH; Wan XS; Rubin H; Schechter NM; Kennedy AR
    Arch Biochem Biophys; 1997 Aug; 344(1):133-8. PubMed ID: 9244390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptidyl human heart chymase inhibitors. 1. Synthesis and inhibitory activity of difluoromethylene ketone derivatives bearing P' binding subsites.
    Eda M; Ashimori A; Akahoshi F; Yoshimura T; Inoue Y; Fukaya C; Nakajima M; Fukuyama H; Imada T; Takai S; Shiota N; Miyazaki M; Nakamura N
    Bioorg Med Chem Lett; 1998 Apr; 8(8):913-8. PubMed ID: 9871511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of daphnodorin A, daphnodorin B and daphnodorin C on human chymase-dependent angiotensin II formation.
    Takai S; Sakaguchi M; Jin D; Baba K; Miyazaki M
    Life Sci; 1999; 64(21):1889-96. PubMed ID: 10353587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzothiopyran-4-one based reversible inhibitors of the human cytomegalovirus (HCMV) protease.
    Dhanak D; Keenan RM; Burton G; Kaura A; Darcy MG; Shah DH; Ridgers LH; Breen A; Lavery P; Tew DG; West A
    Bioorg Med Chem Lett; 1998 Dec; 8(24):3677-82. PubMed ID: 9934494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of inhibitors of the channel-activating protease prostasin (CAP1/PRSS8) utilizing structure-based design.
    Tully DC; Vidal A; Chatterjee AK; Williams JA; Roberts MJ; Petrassi HM; Spraggon G; Bursulaya B; Pacoma R; Shipway A; Schumacher AM; Danahay H; Harris JL
    Bioorg Med Chem Lett; 2008 Nov; 18(22):5895-9. PubMed ID: 18752942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SF2809 compounds, novel chymase inhibitors from Dactylosporangium sp. 1. Taxonomy, fermentation, isolation and biological properties.
    Tani M; Gyobu Y; Sasaki T; Takenouchi O; Kawamura T; Kamimura T; Harada T
    J Antibiot (Tokyo); 2004 Feb; 57(2):83-8. PubMed ID: 15112955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.